Literature DB >> 9160957

Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type.

S M Waters1, T P Davis.   

Abstract

Work in our laboratory has shown that in addition to previously characterized changes in the level of neuropeptides in SDAT brain, the activity of degradative enzymes responsible for peptide metabolism is also affected. In addition to other reported alterations in peptide metabolism, we have observed that SS-28 degradation is increased in Brodmann area 22 whereas substance P degradation is increased in temporal cortex. Changes in the degradation of these neuropeptides known to be affected in SDAT correlate well with alterations in the activity of specific neuropeptidases. Trypsin-like serine protease activity is increased in SDAT Brodmann area 22 which parallels the increased degradation of SS-28. The activity of MEP 24.15 is decreased in temporal cortex which corresponds to the decreased degradation of substance P. Changes in the activity of these degradative enzymes in SDAT brain can potentially affect the action of other neuropeptide substrates because the neuropeptidases discussed here terminate the action of several neuropeptides. As more neuropeptide and degradative peptidase alterations are discovered in SDAT, greater emphasis may be placed on the role that peptides and neuropeptidases play in the progression of SDAT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160957     DOI: 10.1111/j.1749-6632.1997.tb46142.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

Review 1.  The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Authors:  Laura Morelli; Ramiro Llovera; Sandra Ibendahl; Eduardo M Castaño
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

2.  Identification and characterization of Aβ peptide interactors in Alzheimer's disease by structural approaches.

Authors:  Keith D Philibert; Robert A Marr; Eric M Norstrom; Marc J Glucksman
Journal:  Front Aging Neurosci       Date:  2014-10-09       Impact factor: 5.750

Review 3.  The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders.

Authors:  M Brittany Johnson; Ada D Young; Ian Marriott
Journal:  Front Cell Neurosci       Date:  2017-01-04       Impact factor: 5.505

Review 4.  The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease.

Authors:  Robert A Culibrk; Mariah S Hahn
Journal:  Front Aging Neurosci       Date:  2020-12-07       Impact factor: 5.750

5.  Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels.

Authors:  Patrizia Campolongo; Patrizia Ratano; Maria Teresa Ciotti; Fulvio Florenzano; Stefania Lucia Nori; Roberta Marolda; Maura Palmery; Anna Maria Rinaldi; Cristina Zona; Roberta Possenti; Pietro Calissano; Cinzia Severini
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.